HUASHU PHARMACEUTICAL CORPORATION

Company Profile
HUASHU PHARMACEUTICAL CORPORATION

Shijiazhuang Huashu Pharmaceutical Corporation (“Huashu” for short) is China’s largest manufacturer of antibiotic APIs including oxytetracycline, doxycycline hydrochloride, neomycin sulfate and avermectin. Founded in 1987, Huashu is a joint-stock company with 2,200 employees, including 700 engineering technicians.

Over the past 20-odd years, Huashu has accumulated the most valuable asset, an outstanding expert team on antibiotic fermentation. Our leadership has always attached great importance to staff training so that our production and quality management can meet with the international standard.

Huashu boasts China’s largest fermentation production capacity. With a total volume of fermentation tanks over 13,000 cubic meters, and unit volume ranging from 60 to 240 cubic meters, as well as the domestic first-class experiment-grade fermentation facilities, Huashu boasts strong capability from product R&D, pilot production to industrialized production.

more >

Year of Establishment: 1987

Total Assets(USD): choose not to disclose

Total Number of Staff: less than 10 person

Main Competitive Advantages:

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service